Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaclyn F Hechtman

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2018
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomasSandy Liu, Mithat Gӧnen, Zsofia K Stadler, et al.
Science (New York, N.Y.)|May 4, 2019
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy responseRajarsi Mandal, Robert M Samstein, Ken-Wing Lee, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancerSebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Journal of the National Cancer Institute|April 7, 2021
EGFR Amplification in Metastatic Colorectal CancerGiovanni Randon, Rona Yaeger, Jaclyn F Hechtman, et al.
The Oncologist|October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerRyan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Nature Communications|March 9, 2017
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferationInga-Marie Schaefer, Yuexiang Wang, Cher-Wei Liang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing PanelsZsofia K Stadler, Francesca Battaglin, Sumit Middha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial CarcinomaFrançois Audenet, Sumit Isharwal, Eugene K Cha, et al.
The Journal of Clinical Investigation|June 20, 2018
Oncogenic TRK fusions are amenable to inhibition in hematologic malignanciesJustin Taylor, Dean Pavlick, Akihide Yoshimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Characterization and Clinical Outcomes of DNA Mismatch Repair-deficient Small Bowel AdenocarcinomaAlicia Latham, Jinru Shia, Zalak Patel, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2018
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomasSandy Liu, Mithat Gӧnen, Zsofia K Stadler, et al.
Science (New York, N.Y.)|May 4, 2019
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy responseRajarsi Mandal, Robert M Samstein, Ken-Wing Lee, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancerSebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Journal of the National Cancer Institute|April 7, 2021
EGFR Amplification in Metastatic Colorectal CancerGiovanni Randon, Rona Yaeger, Jaclyn F Hechtman, et al.
The Oncologist|October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerRyan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Nature Communications|March 9, 2017
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferationInga-Marie Schaefer, Yuexiang Wang, Cher-Wei Liang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing PanelsZsofia K Stadler, Francesca Battaglin, Sumit Middha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial CarcinomaFrançois Audenet, Sumit Isharwal, Eugene K Cha, et al.
The Journal of Clinical Investigation|June 20, 2018
Oncogenic TRK fusions are amenable to inhibition in hematologic malignanciesJustin Taylor, Dean Pavlick, Akihide Yoshimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Characterization and Clinical Outcomes of DNA Mismatch Repair-deficient Small Bowel AdenocarcinomaAlicia Latham, Jinru Shia, Zalak Patel, et al.
Pageof 12